Advances in infectious disease vaccine adjuvants

J Fan, S Jin, L Gilmartin, I Toth, WM Hussein… - Vaccines, 2022 - mdpi.com
Vaccines are one of the most significant medical interventions in the fight against infectious
diseases. Since their discovery by Edward Jenner in 1796, vaccines have reduced the …

Vaccines against antimicrobial resistance

R Rosini, S Nicchi, M Pizza, R Rappuoli - Frontiers in immunology, 2020 - frontiersin.org
In the last century, life expectancy has increased considerably, thanks to the introduction of
antibiotics, hygiene and vaccines that have contributed to the cure and prevention of many …

Development of a SARS-CoV-2 vaccine candidate using plant-based manufacturing and a tobacco mosaic virus-like nano-particle

JM Royal, CA Simpson, AA McCormick, A Phillips… - Vaccines, 2021 - mdpi.com
Stable, effective, easy-to-manufacture vaccines are critical to stopping the COVID-19
pandemic resulting from the coronavirus SARS-CoV-2. We constructed a vaccine candidate …

[HTML][HTML] Innovative approaches for the control of ticks and tick-borne diseases

J de la Fuente, L Mazuecos, M Contreras - Ticks and Tick-Borne Diseases, 2023 - Elsevier
Ticks and tick-borne diseases constitute a major threat for human and animal health
worldwide. Vaccines for the control of tick infestations and transmitted pathogens still …

Towards A Novel Multi-Epitopes Chimeric Vaccine for Simulating Strong Immune Responses and Protection against Morganella morganii

A Ullah, S Ahmad, S Ismail, Z Afsheen… - International Journal of …, 2021 - mdpi.com
Morganella morganii is one of the main etiological agents of hospital-acquired infections
and no licensed vaccine is available against the pathogen. Herein, we designed a multi …

Fighting back against antimicrobial resistance with comprehensive policy and education: a narrative review

JF Hayes - Antibiotics, 2022 - mdpi.com
Globally, antimicrobial resistance has emerged as a significant threat. A comprehensive
plan is required to combat antimicrobial resistance. There have been national and …

Bacterial-derived outer membrane vesicles are potent adjuvants that drive humoral and cellular immune responses

JT Prior, C Davitt, J Kurtz, P Gellings, JB McLachlan… - Pharmaceutics, 2021 - mdpi.com
Discovery and development of novel adjuvants that can improve existing or next generation
vaccine platforms have received considerable interest in recent years. In particular …

[HTML][HTML] Bacteriophage therapy: recent developments and applications of a renaissant weapon

B Fathima, AC Archer - Research in microbiology, 2021 - Elsevier
Antimicrobial resistance is a global health problem and one of the leading concerns in
healthcare sector. Bacteriophages are antibacterial agents ubiquitous in nature. With …

Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens

S Ismail, S Ahmad, SS Azam - European Journal of Pharmaceutical …, 2020 - Elsevier
Healthcare associated infections (HAIs) are major cause of elevated mortality, morbidity, and
high healthcare costs. Development of a vaccine targeting these pathogens could benefit in …

Quantum vaccinomics platforms to advance in vaccinology

J de la Fuente, M Contreras - Frontiers in Immunology, 2023 - frontiersin.org
The opinion flows from Introduction to the immunological quantum that requires a historical
perspective, to Quantum vaccine algorithms supported by a bibliometric analysis, to …